We, the Editor-in-Chief and Taylor & Francis publishers of Expert Opinion on Therapeutic Patents, are retracting the following article:
Babizhayev MA. Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases 2015 25(11) 1319–1339 https://doi.org/10.1517/13543776.2015.1064899
This is because we have become aware of a significant similarity to previously published articles by the same author, in particular:
Babizhayev MA, Yegorov YE. Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine),Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl-L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic. Recent Patents on Drug Delivery & Formulation 2010 4(3) 198 – 230 DOI: 10.2174/187221110793237547
Babizhayev MA, Nikolayev GM, Nikolayeva JG, Yegorov YE. Biologic Activities of Molecular Chaperones and Pharmacologic Chaperone Imidazole-Containing Dipeptide-Based Compounds: Natural Skin Care Help and the Ultimate Challenge. Implication for Adaptive Responses in the Skin. American Journal of Therapeutics 2012 19(2) p e69–e89 2012. doi: 10.1097/MJT.0b013e3181e71fb7
Babizhayev MA, Kasus-Jacobi A. State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases. Current Clinical Pharmacology 2010 4(1) 4– 7 DOI: 10.2174/157488409787236074
Babizhayev MA, Strokov I, Nosikov VV, Savel’yeva EL, Sitnikov VF, Yegorov YE, Lankin V9. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients. Cell Biochem Biophys. 2015 71(3):1425-43. doi: 10.1007/s12013-014-0365-y.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the guidance of COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.